DIBBS #SPE2DP-26-T-2806

DLA Solicitation for FDA-Regulated Moxifloxacin Hydrochloride Tablets (400 mg, 30-count)

This procurement seeks FDA-regulated Moxifloxacin Hydrochloride Tablets for military supply: - Government Buyer: - Defense Logistics Agency (DLA) Troop Support Medical Supply Chain Pharmacy FSA, Philadelphia, PA - Approved OEMs/Manufacturers: - TEVA Pharmaceuticals USA, Inc. (NDC00093-7387-56) - Dr. Reddy's Laboratories, Inc. (NDC55111-0112-30) - Rising Pharma Holdings, Inc. (NDC57237-0156-30) - Product Requested: - Moxifloxacin Hydrochloride Tablets, 400 mg, 30 tablets per bottle (NSN 6505-01-503-4772) - Quantity: 1 bottle - Unit of issue: bottle - Notable Requirements: - Product must be FDA regulated - Must comply with Medical Marking Standard No. 1A (labeling/marking) - Store at controlled room temperature; avoid high humidity - Delivery required within 20 days FOB destination - Delivery Location: - DDG 127 USS Patrick Gallagher at Bath Iron Works, West Bath, ME

Description

MOXIFLOXACIN HYDROC (QTY: 1, NSN: 6505-01-503-4772, Purchase Request: 7016259866) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 4E8M8, Part No: NDC55111-0112-30, Company: DR REDDY'S LABORATORIES, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.

View original listing